LAUREL COLVIN: Open Payments
NPI 1104499854 · PLATTSBURGH, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,215 in 60 payments from 13 companies in 2025. Trend: 2023 $1,035 · 2024 $1,648 · 2025 $1,215
Food & beverage: $1,215
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $328 |
| Lilly USA, LLC | 7 | $164 |
| Novo Nordisk Inc | 6 | $120 |
| Lundbeck LLC | 5 | $99 |
| PFIZER INC. | 5 | $98 |
| AstraZeneca Pharmaceuticals LP | 5 | $97 |
| Amgen Inc. | 4 | $89 |
| GlaxoSmithKline, LLC. | 4 | $80 |
| Otsuka America Pharmaceutical, Inc. | 3 | $55 |
| Exact Sciences Corporation | 1 | $25 |
Products named: QULIPTA, REXULTI, MOUNJARO, UBRELVY, NURTEC ODT, OTEZLA, Rybelsus, FARXIGA.
Industry payments across NY — which companies pay providers there.
